A comparison of the effects of antitumor agents upon normal human epidermal keratinocytes and human squamous cell carcinoma
- PMID: 2139084
- DOI: 10.1111/1523-1747.ep12876228
A comparison of the effects of antitumor agents upon normal human epidermal keratinocytes and human squamous cell carcinoma
Abstract
The pharmacologic responses of normal and malignant epidermal cells to chemotherapeutic agents were examined in a system which consists of a serum-free "defined" medium. The effects of methotrexate (MTX), fluorodeoxyuridine (FUDR), and hydroxyurea upon cell growth, DNA synthesis, thymidylate synthase activity, and dihydrofolate reductase (DHFR) activity were compared in normal human epidermal keratinocytes (NHEK), newborn epidermal cells (NEC), human squamous cell carcinoma (SCC-25), and a methotrexate-resistant human squamous cell carcinoma (SCC-15R). Normal keratinocytes were found to be 10(3) to 10(4) times less sensitive to the effects of MTX and FUDR than the malignant cells with respect to growth and DNA synthesis. The differential sensitivity to MTX and FUDR was not due to differences in growth media, increased target enzyme activity, e.g., DHFR and thymidylate synthase, or impaired transport of these drugs. The results indicate that the mechanism for the increased sensitivity of the squamous cell carcinoma to MTX and FUDR must involve a process which is distal to the de novo synthesis of dTMP.
Similar articles
-
The mechanism of differential sensitivity to methotrexate of normal and malignant human epidermal cells.Cancer Chemother Pharmacol. 1991;28(3):181-4. doi: 10.1007/BF00685506. Cancer Chemother Pharmacol. 1991. PMID: 1855274
-
Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma.J Invest Dermatol. 1987 Jan;88(1):66-70. doi: 10.1111/1523-1747.ep12465020. J Invest Dermatol. 1987. PMID: 2947954
-
A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.Anticancer Drug Des. 1989 Jun;4(1):79-87. Anticancer Drug Des. 1989. PMID: 2757754
-
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.Biochim Biophys Acta. 2002 Jul 18;1587(2-3):164-73. doi: 10.1016/s0925-4439(02)00079-0. Biochim Biophys Acta. 2002. PMID: 12084458 Review.
-
Molecular mechanisms of resistance to antifolates, a review.Acta Biochim Pol. 1995;42(4):457-64. Acta Biochim Pol. 1995. PMID: 8852336 Review.
Cited by
-
The mechanism of differential sensitivity to methotrexate of normal and malignant human epidermal cells.Cancer Chemother Pharmacol. 1991;28(3):181-4. doi: 10.1007/BF00685506. Cancer Chemother Pharmacol. 1991. PMID: 1855274
-
Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo.Clin Cancer Res. 2009 May 15;15(10):3333-43. doi: 10.1158/1078-0432.CCR-08-3054. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447864 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials